Itaconate As an Inflammatory Mediator and Therapeutic Target in Cardiovascular Medicine
Overview
Affiliations
Inflammation is a critical component of cardiovascular disease (CVD), encompassing coronary artery disease (CAD), cerebrovascular events and heart failure and is the leading cause of mortality worldwide. In recent years, metabolism has been placed centrally in the governance of the immune response. Termed immunometabolism, immune cells adapt cellular metabolic pathways to meet demands of activation and thus function. This rewiring influences not only the bioenergetics of the cell but altered metabolites act as signalling molecules to regulate cellular response. In this review, we focus on the TCA cycle derivative, itaconate, as one such metabolite with promising immunomodulatory and therapeutic potential in inflammatory cardiovascular disease.
Switala L, Di L, Colantonio S, Lakshman B, Caceres T, Reading J ACS Omega. 2025; 10(1):1110-1121.
PMID: 39829496 PMC: 11740141. DOI: 10.1021/acsomega.4c08552.
Hong N, Chaplin A, Di L, Ravodina A, Bevan G, Gao H Cell Rep. 2024; 43(11):114911.
PMID: 39466775 PMC: 11648168. DOI: 10.1016/j.celrep.2024.114911.
Metabolite signaling in the heart.
Flam E, Arany Z Nat Cardiovasc Res. 2024; 2(6):504-516.
PMID: 39195876 DOI: 10.1038/s44161-023-00270-6.
Metabolism Serves as a Bridge Between Cardiomyocytes and Immune Cells in Cardiovascular Diseases.
Hang L, Zhang Y, Zhang Z, Jiang H, Xia L Cardiovasc Drugs Ther. 2024; .
PMID: 38236378 DOI: 10.1007/s10557-024-07545-5.
Ma E, Xing H, Pei J, Zhang Q, Li R, Shen C Ann Transl Med. 2022; 10(16):861.
PMID: 36111043 PMC: 9469154. DOI: 10.21037/atm-22-3388.